Hazard ratios by decade of age of participant for primary and secondary trial outcomes with a significant trend by age are shown in Figure 1 .
← all excerpts
A Reappraisal of Women's Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50-59 Years of Age.
1
—
—